Dr. Michael Abrahamy
"I feel privileged to be a part of the company dedicated to prolonging and improving lives"
Dr. Abrahamy was appointed as Medical Director of the Neopharm Group in 2023. Dr. Abrahamy has vast experience in the pharmaceutical industry after holding positions including Sr. Medical Director of Immunology at Eli Lilly and Medical Manager at MSD. Dr. Abrahamy is a board-certified radiologist who completed his residency training at Shamir Medical Center (Assaf Harofeh), holds an MD degree from Tel-Aviv University and an MBA from the College of Management Academic Studies (COMAS) in Israel with a sub-specialization in biomedicine.